Parameters | Dapagliflozin group | Metformin group | P value |
---|---|---|---|
White blood cell count (/μL) | |||
 Baseline | 6378.6 ± 1553.5 (36) | 6405.0 ± 1507.6 (36) | 0.94 |
 Week 16 | 6532.5 ± 1646.0 (35) | 6372.6 ± 1700.5 (34) | 0.69 |
 Change | 103.8 ± 1166.7 (34) | −106.2 ± 1183.0 (34) | 0.46 |
 P value within group | 0.61 | 0.60 | 0.95 |
Red blood cell count (×104/μL) | |||
 Baseline | 468.9 ± 40.2 (36) | 468.3 ± 41.8 (36) | <0.001 |
 Week 16 | 493.6 ± 41.6 (35) | 456.6 ± 42.9 (34) | <0.001 |
 Change | 26.3 ± 16.3 (34) | −12.0 ± 17.5 (34) |  |
 P value within group | <0.001 | <0.001 |  |
Hemoglobin (g/dL) | |||
 Baseline | 14.3 ± 1.3 (36) | 14.4 ± 1.3 (36) | 0.70 |
 Week 16 | 14.9 ± 1.4 (35) | 14.2 ± 1.7 (34) | 0.05 |
 Change | 0.7 ± 0.5 (34) | −0.2 ± 0.9 (34) | <0.001 |
 P value within group | <0.001 | 0.21 |  |
Hematocrit (%) | |||
 Baseline | 42.6 ± 3.6 (36) | 42.7 ± 3.3 (36) | 0.94 |
 Week 16 | 44.7 ± 3.5 (35) | 41.8 ± 3.6 (34) | 0.001 |
 Change | 2.2 ± 1.4 (34) | −0.9 ± 1.8 (34) | <0.001 |
 P value within group | <0.001 | 0.006 |  |
Platelet count (×104/μL) | |||
 Baseline | 24.0 ± 6.4 (36) | 24.0 ± 5.0 (36) | 0.99 |
 Week 16 | 23.9 ± 6.3 (35) | 24.5 ± 4.7 (34) | 0.64 |
 Change | −0.3 ± 1.5 (34) | 0.5 ± 2.2 (34) | 0.09 |
 P value within group | 0.20 | 0.25 |  |
Uric acid (mg/dL) | |||
 Baseline | 5.6 ± 1.1 (37) | 5.8 ± 1.2 (37) | 0.41 |
 Week 16 | 4.9 ± 1.1 (36) | 5.9 ± 1.1 (36) | <0.001 |
 Change | −0.6 ± 0.7 (36) | 0.1 ± 0.6 (36) | <0.001 |
 P value within group | <0.001 | 0.43 |  |